Assignee
CELLULAR BIOMEDICINE GROUP HK LTD
CN·7 granted patents·2 pending applications·40 citations·filing 2017–2021
Top patents by PatentIndex Score
9 records- 0196US11472858B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Oct 18, 2022·7 cites·4 claims
- 0296US11439665B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Sep 13, 2022·8 cites·4 claims
- 0395US11207349B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Granted Dec 28, 2021·7 cites·5 claims
- 0494US11066457B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2018·Granted Jul 20, 2021·8 cites·8 claims
- 0591US11363812B2Cell freezing medium for clinical useCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2017·Granted Jun 21, 2022·8 cites·11 claims
- 0688US11498973B2BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Nov 15, 2022·1 cites·4 claims
- 0782US11142581B2BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Granted Oct 12, 2021·1 cites·7 claims
- 0849US2022380726A1Universal car-t cell and preparation and use thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Application pending·0 cites
- 0946US2021214682A1Method for preparing chimeric antigen receptor t cells by serum-free cultureCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLULAR BIOMEDICINE GROUP HK LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →